VITA BALANCE 2000 TABLET

מדינה: קנדה

שפה: אנגלית

מקור: Health Canada

מרכיב פעיל:

POTASSIUM (POTASSIUM CITRATE); NICOTINIC ACID; NICOTINAMIDE; FOLIC ACID; BIOTIN; IRON (IRON HVP CHELATE); CALCIUM (CALCIUM HVP CHELATE); MAGNESIUM (MAGNESIUM HVP CHELATE); PHOSPHORUS (PHOSPHORUS HVP CHELATE); ZINC (ZINC HVP CHELATE); MANGANESE (MANGANESE HVP CHELATE); CHROMIUM (CHROMIUM HVP CHELATE); SELENIUM (SELENIUM HVP CHELATE); CHOLINE (CHOLINE BITARTRATE); INOSITOL; DL-METHIONINE; VITAMIN A (RETINOL PALMITATE); BETA-CAROTENE (PROVITAMIN A); VITAMIN D3 (CHOLECALCIFEROL); VITAMIN E (D-ALPHA TOCOPHEROL); VITAMIN B1 (THIAMINE HYDROCHLORIDE); VITAMIN B2; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); VITAMIN B12 (CYANOCOBALAMIN)

זמין מ:

NEW SPIRIT NATURALS, INC.

INN (שם בינלאומי):

BETA-CAROTENE (PROVITAMIN A), BIOTIN, CALCIUM (CALCIUM HVP CHELATE), CHOLINE (CHOLINE BITARTRATE), CHROMIUM (CHROMIUM HVP CHELAT

כמות:

20MG; 8MG; 8MG; 0.0133MG; 8MCG; 3MG; 150MG; 75MG; 125MG; 6MG; 8MG; 20MCG; 15MCG; 9MG; 9MG; 9MG; 1600UNIT; 1100UNIT; 75UNIT; 33UNIT; 8MG; 8MG; 8MG; 40MCG

טופס פרצבטיות:

TABLET

הרכב:

POTASSIUM (POTASSIUM CITRATE) 20MG; NICOTINIC ACID 8MG; NICOTINAMIDE 8MG; FOLIC ACID 0.0133MG; BIOTIN 8MCG; IRON (IRON HVP CHELATE) 3MG; CALCIUM (CALCIUM HVP CHELATE) 150MG; MAGNESIUM (MAGNESIUM HVP CHELATE) 75MG; PHOSPHORUS (PHOSPHORUS HVP CHELATE) 125MG; ZINC (ZINC HVP CHELATE) 6MG; MANGANESE (MANGANESE HVP CHELATE) 8MG; CHROMIUM (CHROMIUM HVP CHELATE) 20MCG; SELENIUM (SELENIUM HVP CHELATE) 15MCG; CHOLINE (CHOLINE BITARTRATE) 9MG; INOSITOL 9MG; DL-METHIONINE 9MG; VITAMIN A (RETINOL PALMITATE) 1600UNIT; BETA-CAROTENE (PROVITAMIN A) 1100UNIT; VITAMIN D3 (CHOLECALCIFEROL) 75UNIT; VITAMIN E (D-ALPHA TOCOPHEROL) 33UNIT; VITAMIN B1 (THIAMINE HYDROCHLORIDE) 8MG; VITAMIN B2 8MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 8MG; VITAMIN B12 (CYANOCOBALAMIN) 40MCG

מסלול נתינה (של תרופות):

ORAL

יחידות באריזה:

100

סוג מרשם:

Schedule G (CDSA IV)

leaflet_short:

Active ingredient group (AIG) number: 2431832001

מצב אישור:

CANCELLED (UNRETURNED ANNUAL)

תאריך אישור:

2018-04-04